Efalizumab
Trovati 2 articoli
- Raptiva associated with progressive multifocal leukoencephalopathy
- Raptiva ( Efalizumab ) is an immunosuppressive, humanized monoclonal antibody indicated for treatment of adult patients with moderate to severe chronic plaque psoriasis who have failed to respond to, or who have a contraindication to, or who have a contraindication to, or are intolerant to other ... (Leggi Articolo)
- Raptiva linked to immune-mediated haemolytic anemia
- Raptiva ( Efalizumab) is indicated for the treatment of adult patients ( 18 years or older ) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Genentech has revised the Prescribing Information including a new warning regarding events of i... (Leggi Articolo)
